JIA | Oligoarticular JIA | Polyarticular JIA | |
---|---|---|---|
Male/Female | 9/27 (25%/75%) | 3/13 (19%/81%) | 6/14 (30%/70%) |
Age range in years (median) | 3.5–18.9 (11.4) | 3.5–16.6 (11.7) | 4.9–18.9 (10.9) |
Disease durationa | 5.1 (3.3) | 5.2 (4.0) | 5.0 (2.8) |
Disease activity (active/remission) | 22/14 (61%/39%) | 9/7 (56%/44%) | 13/7 (65%/35%) |
RF-positive | 2 (6%) | 0 | 2 (10%) |
ANA-positive | 21 (58%) | 11 (69%) | 10 (50%) |
Uveitis | 3 (8%) | 2 (13%) | 1 (5%) |
NSAID use | 30 (83%) | 11 (69%) | 19 (95%) |
Sulfasalazine and/or methotrexate use | 10 (28%) | 2 (13%) | 8 (40%) |